Razpipadon
id:
razpipadon-176-18351743
title:
Razpipadon
text:
Razpipadon is a dopamine receptor agonist which is under development for the treatment of dementia-related apathy. It was originated by Pfizer and is under development by Cerevel Therapeutics. Razpipadon acts as a selective partial agonist of the dopamine D1 and D5 receptors. It is taken via oral administration. As of April 2022, razpipadon is in phase 2 clinical trials for dementia-related apathy.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Razpipadon
date created:
2023-02-03T00:30:00Z
date modified:
2024-09-03T21:26:49Z
main entity:
{"identifier":"Q116797322","url":"https://www.wikidata.org/entity/Q116797322"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/4/43/Razpipadon.svg","width":655,"height":385}
fields total:
13
integrity:
16